Cargando…
The safety and efficacy of high versus low vancomycin trough levels in the treatment of patients with infections caused by methicillin-resistant Staphylococcus aureus: a meta-analysis
BACKGROUND: Recent guidelines have recommended vancomycin trough levels of 15–20 mg/L for treatment of serious infections caused by methicillin-resistant Staphylococcus aureus (MRSA). However, high trough levels may increase risk of nephrotoxicity and mortality, and high vancomycin trough levels hav...
Autores principales: | Tongsai, Sasima, Koomanachai, Pornpan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5041442/ https://www.ncbi.nlm.nih.gov/pubmed/27686168 http://dx.doi.org/10.1186/s13104-016-2252-7 |
Ejemplares similares
-
Prevalence and Accuracy of Screening Test of Asymptomatic Bacteriuria During Pregnancy in Siriraj Hospital
por: Srisompong, Jintana, et al.
Publicado: (2017) -
Impact of Initial Vancomycin Trough Concentration on Clinical and Microbiological Outcomes of Methicillin-Resistant Staphylococcus aureus Bacteremia in Children
por: Yoo, Ree Nar, et al.
Publicado: (2017) -
The association of vancomycin trough levels with outcomes among patients with methicillin-resistant Staphylococcus aureus (MRSA) infections: Retrospective cohort study
por: Yahav, Dafna, et al.
Publicado: (2019) -
Efficacy and Safety of Daptomycin versus Vancomycin for Bacteremia Caused by Methicillin-Resistant Staphylococcus aureus with Vancomycin Minimum Inhibitory Concentration > 1 µg/mL: A Systematic Review and Meta-Analysis
por: Samura, Masaru, et al.
Publicado: (2022) -
Vancomycin Heteroresistance in Methicillin-resistant Staphylococcus aureus, Taiwan
por: Wang, Jiun-Ling, et al.
Publicado: (2004)